You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Stage 1 small cell cancer of the vagina
  1. Tarek Haykal,
  2. Trailokya Pandit,
  3. Ghassan Bachuwa,
  4. Rizwan Danish
  1. Department of Internal Medicine, Hurley Medical Center, Flint, Michigan, USA
  1. Correspondence to Dr Ghassan Bachuwa, gbachuw2{at}hurleymc.com

Summary

This is the case of a 56-year-old white woman with a medical history significant for chronic obstructive pulmonary disease, migraine, hypertension, tobacco abuse and hypercholesterolaemia. Her surgical history is significant for total hysterectomy and bilateral salpingo-oophorectomy for diffuse endometriosis. The patient presented with a vaginal lesion. The biopsy was positive for primary vaginal small cell carcinoma and human papilloma virus (HPV). Initial staging positron emission tomography (PET) scan confirmed stage 1 disease. The patient was started on chemotherapy with cisplatin and etoposide for four cycles, followed by concurrent chemotherapy with cisplatin/taxol and radiation therapy.

  • malignant disease and immunosuppression
  • obstetrics, gynaecology and fertility
  • urinary and genital tract disorders

https://doi.org/10.1136/bcr-2018-225294

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors TH: primary author, idea, concept, design, data acquisition and writing of the manuscript. TP: second author, editing of the manuscript, interpretation of the results and data. GB: corresponding author, editing the manuscript, interpretation of the data, concept, design and reporting. RD: editing of the manuscript, data acquisition and analysis.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.